Physical activity and mortality in melanoma patients within the Norwegian Women and Cancer study (<scp>NOWAC</scp>)
Pre- and post-diagnosis physical activity (PA) have been associated with decreased mortality and recurrence in cancer patients, but its effect is under-studied in patients with cutaneous melanoma. We investigated the association between pre-diagnosis PA (most recent level and long-term trajectories) and melanoma-specific, other-cause, and overall mortality. Additionally, PA levels before and after a melanoma diagnosis were compared. We used information at recruitment and follow-ups in the prospective population-based Norwegian Women and Cancer cohort linked to the Cancer Registry of Norway. In total 1829 women were diagnosed with a first primary melanoma in 1991─2020, aged 34-93 years. We used Cox regression adjusted for age at diagnosis, education, smoking status, region of residence, melanoma thickness, and summary stage. Most recent pre-diagnosis PA was non-significantly associated with lower risk of melanoma-specific mortality (hazard ratio (HR) = 0.69, 95% confidence interval (CI) = 0.44─1.07, high vs. low) and significantly associated with other-cause (HR = 0.50, 95% CI = 0.28─0.89) and overall mortality (HR = 0.59, 95% CI = 0.42─0.82). Four pre-diagnosis PA trajectory classes were identified using a latent class mixed model (low, decreasing, moderate, and high). The PA trajectory classes were not significantly associated with melanoma-specific mortality. However, significantly decreased risks of other-cause (HR = 0.51, 95% CI = 0.30─0.87) and overall mortality (HR = 0.59, 95% CI = 0.42─0.84) were found in the moderate versus low class. Only 275 patients reported both pre- and post-diagnosis PA, and among those, 69% had a similar PA level before and after melanoma diagnosis. Our results suggest that pre-diagnosis PA reduces mortality in middle-aged Norwegian women with melanoma.
Authors
- Morten Valberg
- Flavie Perrier (ORCID: https://orcid.org/0000-0001-6979-9656)
- Marit B. Veierød (ORCID: https://orcid.org/0000-0002-2083-2758)
- Corina S. Rueegg (ORCID: https://orcid.org/0000-0003-3720-4659)
- Adèle C. Green (ORCID: https://orcid.org/0000-0002-2753-4841)
- Ashley Ahimbisibwe (ORCID: https://orcid.org/0000-0003-2514-7722)
- Reza Ghiasvand (ORCID: https://orcid.org/0000-0002-5466-7308)
- Kristin Benjaminsen Borch (ORCID: https://orcid.org/0000-0002-1741-2322)
- Tonje Braaten (ORCID: https://orcid.org/0000-0003-4394-6149)
- Trude Eid Robsahm (ORCID: https://orcid.org/0000-0002-1652-7734)
- Elisabete Weiderpass (ORCID: https://orcid.org/0000-0003-2237-0128)
Institutions
- Oslo University Hospital (NO)
- Norwegian Institute of Public Health (NO)
- University of Oslo (NO)
- University of Zurich (CH)
- QIMR Berghofer Medical Research Institute (AU)
- University of Manchester (GB)
- Cancer Research UK Manchester Institute (GB)
- Cancer Registry of Norway (NO)
- Centre international de recherche sur le cancer (FR)
- UiT The Arctic University of Norway (NO)
Publication Details
- Journal
- International Journal of Cancer
- Published
- 2025-04-03
- DOI
- https://doi.org/10.1002/ijc.35430
- Citations
- 1
- Primary Topic
- Cutaneous Melanoma Detection and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- Kreftforeningen
- Norges Forskningsråd